Metraipolis › archive › dc_35970f643b13
Second Primary Malignancy in Ixazomib Maintenance Therapy for Multiple Myeloma: Case Report and Literature Review — Europe PMC PMID:41306911
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41306911
- DOI
- 10.1155/crh/6814237
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T11:26:37.108Z
- SHA-256 of the archived text
5535a62baad4bc7e8d023aa7fa6321892eb71d69816bfcc2de40e2c8a1d57679- Stable URL of this page
https://metraipolis.com/documento/dc_35970f643b13
How to cite
Second Primary Malignancy in Ixazomib Maintenance Therapy for Multiple Myeloma: Case Report and Literature Review — Europe PMC PMID:41306911 — Europe PMC (en), https://europepmc.org/article/MED/41306911 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_35970f643b13 (Metraipolis archive dc_35970f643b13, sha256 5535a62baad4bc7e8d023aa7fa6321892eb71d69816bfcc2de40e2c8a1d57679)
BibTeX
@misc{dc35970f643b13,
title = {Second Primary Malignancy in Ixazomib Maintenance Therapy for Multiple Myeloma: Case Report and Literature Review — Europe PMC PMID:41306911},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41306911},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_35970f643b13; sha256 5535a62baad4bc7e8d023aa7fa6321892eb71d69816bfcc2de40e2c8a1d57679},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41306911. Agents can read the archived copy with the MCP tool read_document.